Sunday - December 22, 2024

Cell Assembly-Mediated Delivery of Checkpoint Inhibitors for Cancer Immunotherapy

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- NORTH CAROLINA STATE UNIVERSITY, Raleigh, North Carolina has been assigned a patent (No. US 12161720 B2, initially filed April 8, 2019) developed by Zhen Gu, Los Angeles, California, and Quanyin Hu, Jamaica Plain, Massachusetts, for "Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Cell Assembly-Mediated Delivery of Checkpoint Inhibitors for Cancer Immunotherapy

Information Request Form

Copyright Targeted News Service 2024